UBS Group »

Atyr Pharma shares owned by UBS Group

Quarter-by-quarter ownership of Atyr Pharma (LIFE) shares owned by UBS Group from 13F filings

Historical chart of UBS Group investment in Atyr Pharma

Tip: Access up to 7 years of quarterly data

All positions including Atyr Pharma held by UBS Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Atyr Pharma by UBS Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $23k 16k 1.41
2023-09-30 $6.9k 4.4k 1.58
2023-03-31 $2.1k 1.0k 2.10
2022-09-30 $18k 6.0k 3.01
2022-06-30 $6.0k 2.0k 3.00
2022-03-31 $21k 4.0k 5.25
2021-12-31 $8.0k 1.1k 7.07
2021-06-30 $15k 3.2k 4.74
2020-09-30 $5.0k 1.6k 3.05
2020-06-30 $178k 40k 4.44
2020-03-31 $106k 38k 2.79
2019-12-31 $14k 3.4k 4.06